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Patrícia Isabel Amaro 
 
As an applied research project, the purpose of this dissertation is to develop a suitable 
framework for health-tech companies to evaluate and monitor their mobile-based health 
technologies’ efficacy and usability, whilst defining features and maximizing 
performance. Indeed, since no officially recognized standards exist for mobile health 
(mHealth) apps evaluation, despite the fact they can produce health or behavioral 
benefits, this crucial assessment is often overlooked by companies and poorly integrated 
into planning.   
This research illustrates four mHealth evaluation frameworks and describes the 
assessment plan that has been developed for The Weal Life app, a socially connected 
app targeted to caregivers and circle of support.  
Ultimately, and this is our main finding, we identified two necessary conditions for 
health-tech companies to maximize their mHealth apps evaluation and performance. 
The first is to embrace a strategic approach that aligns both the mobile health 
intervention and app development goals, and the second is to assess the impact of these 
technologies. Indeed, we show that impact measurement process plays the role of 
“information systems” allowing companies not only to quantify the impact of their 
products, but also to monitor and improve their performance constantly.    
The detail of The Weal Life assessment plan will ensure the findings add to evidence 
and have broad relevance to healthcare professionals and researchers in general.  
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Desenvolver planos de avaliação para intervenções mHealth: Um estudo de caso sobre 
The Weal Life app  
 
Autor 
Patrícia Isabel Amaro 
 
Enquanto projeto de pesquisa, o objetivo desta dissertação é desenvolver diretrizes 
adequadas para as empresas de tecnologias da saúde avaliarem e monitorizarem a 
eficácia e usabilidade das suas tecnologias móveis, paralelamente definindo 
especificidades e aumentando o desempenho. Com efeito, uma vez que não existem 
linhas de orientação reconhecidas no que toca à avaliação de aplicações mHealth, apesar 
das mesmas poderem ser benéficas para a saúde e comportamento, este estudo crucial é 
amiúde desprezado por empresas e pobremente executado. 
Esta pesquisa ilustra quatro formas de avaliação mHealth e descreve o plano de teste 
que foi desenvolvido para a app The Weal Life, uma aplicação social orientada para os 
cuidadores e círculo de apoio.  
Em síntese, identificámos duas condições necessárias para que empresas tecnológicas 
na área de saúde possam maximizar a avaliação e performance das suas aplicações 
mHealth. A primeira consiste em aplicar uma abordagem estratégica que alinhe ambos 
os objetivos da intervenção tecnológica e do desenvolvimento da aplicação; a segunda, 
e mais importante, é avaliar corretamente o impacto destas mesmas tecnologias na 
população-alvo e sociedade em geral. De facto, concluímos que a avaliação funcionará 
como um “sistema de informação” atualizado, permitindo às empresas quantificar, 
monitorizar e melhorar a performance dos seus produtos.  
O detalhe do plano de avaliação da The Weal Life vai fundamentar os resultados postos 
em evidência e ser relevante para os profissionais de saúde e investigadores em geral. 
 
Palavras-chave: cuidar, métodos de avaliação, tecnologias mHealth, mHealth app, 
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In the beginning of 2015, there were over 259,000 health and fitness related apps 
available in the two major app stores (i.e. Apple and Android) (Research2Guidance, 
mHealth Economics Research Program, 2016). In a socioeconomically and 
geographically diverse sample survey of the US population, Brand., L., and colleagues 
(2015) found 58,23% of mobile phone owners to have downloaded a health-related app. 
Yet, despite the proliferation and its acclaimed properties, there remains a lack of 
evidence of the efficiency and impact these mobile health interventions can have in 
terms of health outcomes and behavioral change. 
As evidence and knowledge are a crucial part of health promotion and implementation, 
the present research discusses the need for mHealth interventions to be evaluated within 
a comprehensive framework. Describing its implementation process in a socially 
connected mHealth app targeted to caregivers - The Weal Life app – this dissertation 
aims to answer the following research questions  
1. Synthetize why health-tech companies should evaluate their mHealth app 
technologies 
2. Evaluate the importance and need to adopt a comprehensive approach to 
mHealth apps and to undertake impact measurement 
3. Examine how mHealth Apps should be measured  
As a foundation for The Weal Life app assessment plan, we’ll firstly conduct a thorough 
review on mHealth technologies, evidence and existing frameworks for its evaluation. 
Secondly we’ll leverage this knowledge in order to build a holistic structure for mobile 
based health interventions evaluation and monitoring. Thirdly, we’ll draw conclusions, 
recommend a practical approach to be applied in classes, acknowledge limitations and 
recommend future research.     
The Weal Life is a health-tech startup based in San Francisco, California, founded by 
Keely Stevenson, with the purpose to help family caregivers to cope with the main 
caregiving challenges and responsibilities. Finally, our main goal is to provide The Weal 
Life a reliable, multidimensional tool for evaluating its mHealth technology, whilst 
ensuring its intervention to deliver real value to the end users, thus facilitating the 
caregiving experience. Given the general nature of the assessment plan developed in 







In order to address the research questions, a qualitative approach in the form of a single 
case study will be used.   
In the context of the collaboration with The Weal Life we developed a tailored 
“Assessment Plan” into the case study, explaining the necessary methodology to 
quantify and qualify its mHealth app technology benefits and externalities – The Weal 
Life App. Throughout the entire process, we attended weekly meetings with The Weal 
Life founders (Keely Stevenson and Josephine Lai) in order to identify main challenges, 
concerns and objectives in evaluating their technology. In a jointly effort we developed 
the final framework. For the purpose, both primary (i.e. company records and weekly 
meetings with The Weal Life team) and secondary data were collected and analyzed. In 
addition, we did a single interview with the Founder and CEO of Tyze1, Vickie 
Cammake. Vickie Cammake is a known and acknowledge entrepreneur in the mHealth 
US industry. Having found her own mHealth tech company, Vickie widened our 
perspectives by highlighting the need for mobile based health interventions to be 
holistically evaluated.      
As a starting point, research explored the current state of mHealth adoption and 
development. Secondly we identified the main challenges in evaluating and generating 
evidence-based knowledge of mHealth interventions’ efficacy. Finally, building on four 
developed models for socially connected and mHealth apps evaluation, we mapped 
together all the information into a final comprehensive assessment plan for The Weal 
Life to properly evaluate and maximize its mHealth technology performance. 
Throughout the entire process,   
 
3. Literature Review 
  
3.1 mHealth: Supporting Health through Technology 
 
“Mobile technologies are mobile and popular, such that many people carry their 
mobile phone with them wherever they go. This allows temporal synchronization of the 
                                                






intervention delivery and it allows the intervention to claim’s people’s attention when 
it’s most relevant.” 
Free, C., et al., 2013 
 
Promising to improve healthcare delivery, efficiency and affordability, mobile health 
technology or simply mHealth proposes to deliver healthcare anytime and anywhere, 
surpassing geographical, temporal and even organizational barriers (Silva, B., et al., 
2015). For the healthcare professional, a mobile device has become an integral part of 
delivering care, whilst patients have taken an active role in managing their health.  
As a new and emergent field, mHealth lacks a standardized definition. Laxminarayan, 
S., & Istepanian, S., (2000) defined mHealth for the first time as “unwired e-med”. In 
2011, the Global Observatory for eHealth at the World Health Organization described it 
as a “medical and public health practice supported by mobile devices, such as mobile 
phones, patient monitoring devices, personal digital assistants (PDAs), and other 
wireless devices” involving “the use and capitalization on a mobile phone’s core utility 
of voice and SMS as well as more complex functionalities and applications including 
GPRS, third and fourth generation mobile communications (3G and 4G systems), GPS 
and Bluetooth technology”. In a more general approach, Istepanian, R., and colleagues, 
(2006) defined mHealth as “the emerging mobile communications and network 
technologies for healthcare systems”. 
As it stands, mHealth is a broader term for a myriad of emerging technologies that 
leverage the scope and speed of mobile networks in order to improve healthcare 
delivery. In healthcare, the use of mHealth interventions have the potential to improve 
health outcomes and reduce the cost of care by allowing efficient communication and 
the simplification of care (Silva, B., et al., 2015). These technologies can support 
continuous health monitoring, encourage health behaviors, support patient chronic 
disease self-management, enhance provider’s knowledge, reduce the number of 
healthcare visits, and provide personalized, on-demand interventions (Kumar, S., et al., 
2014). On the other hand, concerns regarding safety, privacy of medical information 








3.2 The Rise of mHealth Apps: “There’s an App for That” 
With the rising of mHealth and Smartphone technology, health-related mobile 
applications2 (apps) have become highly popularized. Since the beginning of 2015, 
almost 100,000 apps have been added to the major stores (i.e. Apple store and Android 
app store), amounting to 259,000 mHealth apps currently available 
(Research2Guidance, mHealth Economics Research Program, 2016). In a 
socioeconomically and geographically diverse sample survey of the US population, 
Brand., L., and colleagues (2015) found 58,23% of mobile phone owners to have 
downloaded a health-related app. Because most Americans own a smartphone, mobile 
technologies are a mean to impact health information dissemination and health 
promotion.  
Available apps cover a range of healthcare topics including, wellness & lifestyle, 
dieting, disease management, fitness and public health. Across the patient spectrum, 
mHealth apps will provide an opportunity to collect and deliver tailored health 
information, whilst improving disease self-management and health behavior over time. 
These can be divided into two broad categories: (1) those specifically focused on 
disease management interventions (e.g. diabetes monitoring), and (2) those targeted to 
health behavior change (e.g. smoke cessation programs) (Free, C., et al., 2013).  
The widespread use of this technology will have the potential to move healthcare from 
episodic to continuous care through constant innovation (Kratzke, C. & Cox, C., 2012). 
Compared to stationary intervention programs, mHealth apps have the potential to be 
highly interactive and include real-time communication with individuals3, thus allowing 
the patients to make decisions and take immediate actions. Using mHealth monitoring, 
physicians can send and receive patient information in real time using smartphones for 
motivation, patient adherence, decision support or behavior modification (Fukuoka, Y., 
et al., 2011; Vervloet, M., et al., 2011). This may improve the patient-provider 
relationship and support. Through mobile-based technologies, medical references may 
be accessed in resource limited areas and remote locations (Chang, Y., et al., 2012). 
However, these “medical apps” also raise several and complex questions regarding 
                                                
2	Mobile	applications	or	apps,	are	dowloadable	software	products	that	run	in	mobile	devices	(Kratzke	C.	&	Cox,	C.,	
2012)		







security, reliability, efficiency and quality of service (Silva, B., et al., 2015). As 
healthcare providers may consider the integration of smartphones and mHealth apps as 
a part of the treatment process, it is important to understand how the use of these 
technologies can leverage health interventions.   
 
 
3.2.1 Do mHealth Apps Really Provide Benefits? 
While more than a third of US physicians claim to have recommended health-related 
apps to their patients, (Manhattan Research’s Taking the Pulse, 2014) there remains 
uncertainty in doing it so. The lack of evidence for mHealth apps’ effectiveness in 
improving health outcomes and/or changing health behavior continues to be a barrier to 
the widespread adoption of apps in the healthcare sector. 
Whilst systematic reviews are developed, the majority focus on whether apps for a 
specific condition or health behavior are rooted in evidence-based strategies or 
theoretical models of behavior change (Boudreaux, E., et al., 2014). Examples include 
reviews of mHealth apps for cancer prevention and management (Bender, L., et al., 
2013), weight loss (Pagoto, S., et al., 2013; Breton R., et al., 2011), mental health 
(Donker, T., et al., 2013), chronical medical conditions (Martinez-Perez, B., et al., 2013; 
El-Gayar, O., et al., 2013), HIV prevention (Muessig, E., et al., 2013), and medication 
self-management (Bailey, C., 2014).     
In a meta-analysis aimed to quantify the effectiveness of mobile technology-based 
interventions delivered to healthcare consumers for health behavior change and disease 
management, researchers found little or no evidence regarding the benefits of these 
interventions (Free, C., et al., 2013). From 59 study trials, Free, C., and colleagues 
report only two mHealth app technologies to be considered for inclusion in healthcare 
services: (1) a mobile phone short message service (that uses SMS to maintain contact, 
monitor and respond to medication issues with patients prescribed anti-retrovirals) in 
Kenya, that showed an increased adherence to anti-retrovirals and clinical important 
reductions in the viral load (Lester, T., et al., 2010), and (2) an automated text message 
intervention smoking cessation support that more than doubled biochemically 
confirmed smoking cessation in the UK (Free, C., et al., 2009; Free, C., et al., 2011). To 






implementation of these interventions in other areas of self-management disease or 
health behavior change (Free, C., et al., 2013).  
Lack of information, the heterogeneity of study designs and risk of bias make it difficult 
to conduct rigorous reviews. Paradoxically, as greater healthcare stakeholders’ 
involvement is required to improve the development of evidence-based apps, the fast-
paced growth of the health-related app market outpaces their ability to develop guidance 
for accuracy, efficacy and security. Currently, evidence is sparse for the efficiency and 
cost effectiveness of this technology. This is considered to be the major barrier to the 
implementation of mHealth apps in the healthcare sector (World Health Organization, 
2011) and highlights the need for comprehensive evaluation plans for such 
interventions.   
 
3.3 Evaluating mHealth Apps: A Condition to Leverage Externalities 
 
“Effective evaluation is not an ‘event’ that occurs at the end of a project, but is an 
ongoing process which helps decision makers better understand the project; how it is 
impacting participants, partner agencies and the community; and how it is being 
influenced by both internal and external factors”  
 
WK Kellogg Foundation, (2004) 
 
mHealth apps are thriving, but before healthcare providers or organizations can 
recommend an app, they need to be confident the technology will be user-friendly and 
helpful for the patients they serve (Boudreaux, E., et al., 2014). Although these 
technologies may seem appealing, research is needed to assess when, where and for 
whom mHealth devices are efficient (Kumar, S., et al., 2014). Recommending an app to 
a patient may have serious consequences if its content is inaccurate or if the app is 
ineffective or even harmful (Boudreaux, E., et al., 2014). In a recent study, Wolf, A., 
and colleagues (2013) found 3 out of 4 smartphone apps in assessing melanoma risk 
misclassified 30% or more of melanomas. Reliance on these apps, (which are not 
regulated) have the potential to delay the diagnosis and treatment for a condition in 






development of smartphone apps has not traditionally included healthcare professionals 
input and no standardized evaluation tools are available for health specialists to review 
content quality of health-related apps (Kratzke, C., & Cox, C., 2012). As with any other 
procedure, before mobile-based health assessment methods can be recommended, their 
reliability must be established (Barnhart, X., at al., 2007) and guidance on how to judge 
their commercial value must be acknowledged (Boudreaux, E., et al., 2014).  
To date, little or no quality control exist to ensure mHealth quality and validity. The 
Food and Drug Administration (FDA) does not regulate most mHealth apps and further 
suggests that it does not intend to expand regulation to non-medical devices (United 
States Food and Drug Administration, 2014). To clarify the question if smartphones can 
be classified as medical devices (thus regulated by the FDA), the FDA proposed to 
amend its regulations governing classification of medical devices, releasing in February 
2015, a new guidance for mobile apps. The FDA states “when the intended use of a 
mobile app is for diagnosis of disease or other conditions, or the cure, mitigation, 
treatment, or prevention of disease, or is intended to affect the structure of any function 
of the body of man, the mobile app is a medical device” (U.D. of Health, 2015) 
Consequently, as these initiatives proliferate, academic researchers develop several 
models and tools to guide its evaluation (White, B., et al., 2016). The following four 
approaches balance the efficiency of the research process against the need to evaluate 
the accuracy and validity of a mHealth app.  
 
3.3.1 Collaborative Adaptive Interactive Technology 
In 2009, Grady, L., and colleagues developed the “Collaborative Adaptive Interactive 
Technology” dynamic framework. Whilst developed for web-based interventions, the 
framework is adjustable and particularly significant for mHealth applications that 
connect people and groups. This evaluation tool is particularly relevant for our project 
as it aims to evaluate the end user (not specifically the patient) and all the people 
involved (i.e. a socially connected app) in using or developing the mHealth app. As 
stated in the original work, “people contains parameters related to the individuals who 
are involved in using or developing the technology, or may be affected by the 






In their research, the authors define “collaborative, adaptive and interactive 
technologies” as those that (1) facilitate collaboration between users, (2) adapt content 
according to users’ needs and (3) enable user interaction (O’Grady, L., et al., 2009). 
Additionally, the concept encompasses five major aspects of health applications: (1) 
social networking, (2) participation, (3) apomediation, (4) collaboration, and (5) 
openness. 
The framework organizes formative (i.e. development and laboratory testing), 
summative (i.e. efficacy and goal achievement), and outcomes (i.e. impact assessment) 
indicators into five major areas:       
1 – People: end users and stakeholders  
2 – Content: information and web content  
3 – Technology: technology used to create and develop the website 
4 – Computer-Mediated Interaction: assessment of user interactions with and via the 
technology 
5 – Health Systems Integration: how the website impacts the broader health system, 
processes and the society 
 
Table 1 – Evaluation schema: collaborative, adaptive and interactive technology (O’Grady, L., and colleagues, 2009)  
 
Formative 
Development and laboratory 
testing 
Summative 








• Assessment of 
stakeholders’ interests 





• End users’ 
perspectives (intention 
to use, satisfaction, 
motivation to use) 
• Patient outcomes 






• Quality and credibility 
• Utility (completeness, 
relevance, 
understandability) 
• Quality and credibility 
• Subjective utility 
• Level of 
personalization 
• Content produced 
(form and nature) 




• System robustness 
(performance, 
• Usage statistics (hits, 
visitors, browsers, 














• System reliability 
• Speed 
• Positioning within 
current technology 
• Standards compliance 
development models 

























• Definition of 







• Public impact 
• Cost-effectiveness 




3.3.2 Mobile Application Rating Scale 
The Mobile Application Rating Scale (MARS) was developed by Stoyanov, S., and 
Psych, M., in 2015. This recently developed tool evaluates the quality of a mHealth App 
by addressing five broad categories of criteria:  
1- Engagement: entertainment, interest, customization, interactivity and target 
group fitting 
2- Functionality: performance, ease of use, navigation and gestural design   
3- Aesthetics: layout, graphics and visual appeal 
4- Information Quality: accuracy of the app description, goals, quality of 
information, quantity of information, visual information, credibility, and 
evidence base 
5- Subjective Quality Scale: users’ opinion (e.g. Would you recommend this app to 
people who might benefit from it?) 
Each item uses a 5-point scale (1 – Inadequate, 2 – Poor, 3 – Acceptable, 4 – Good, 5 - 
Excellent) and it is scored by calculating the mean values of the four objective subscales 






total score.  This tool can  be easily incorporated into an app  development  process, 
identifying areas of weakness and strength, or used to rate an already existing app. 
 
3.3.3 Trial of Intervention Principles  
In  2015,  Mohr,  D., and coleagues suggested traditional randomized controled trials 
(RCTs)  methodologies  not to  be ideal for evaluating “Behavioral Intervention 
Technologies” (BITs), (i.e. eHealth and mHealth interventions expected to be modified 
frequently), as “RCTs  usualy test early  versions  of BITs that  often have to  undergo 
revisions prior to implementation” (Mohr, D., et al., 2015) and researchers often refuse 
to improve the BIT during the RCT (based on new trial information, such as bugs and 
erors). 
In their work, the “Trial of Intervention Principles” (TIPs) analysis focus on assessing 
evaluation and intervention  principles, alowing for  ongoing  quality improvements to 
the technology, (as opposed to a static traditional version of RCTs). 
Mohr, D., and coleagues (2015) start by recommending a specific BIT framework (See 
Figure 1) including two broader categories: (1) a conceptual action level (fixed) which 
reflects the intentions  of the intervention (i.e.  why the  BIT exists), and (2) an 
instantiation category (dynamic, i.e. that can  be adjusted  during the trial) that reflects 
the technological implementation (i.e. what is delivered, when and how). 
Figure 2 places the BIT model into the context of TIPs. Aspects included in the doted 
box should not be changed during the course of a RCT. Instantiation components (if not 
a part of the principles) can be adjusted during the trial. The outcomes box represents 
the measurement of intervention outcomes.  









Usualy, the  decision to change a  BIT is  made  due to a  belief, that a specific 
instantiation component – elements, characteristics  or  workflow - is  producing 
suboptimal usage or intervention outcomes. 
Thus, the TIPs framework integrates adjustments and quality improvements into RCTs, 
(as long as changes are reported) alowing for ongoing learning and optimization of the 
tested technology. 
 
3.3.4 World Health Organization Evidence Reporting and Assessment Checklist 
In 2016, the WHO mHealth Technical Evidence Review Group (mTERG) developed a 
mHealth evidence reporting and assessment (mERA) checklist consisting  of 16  key 
criteria (See Table 2) (Agarwal, S., Lefevre, A., et al., 2016). The checklist identifies a 
minimum set  of information  needed to  outline (1)  what the  mHealth intervention is 
(content), (2) where it is being implemented (context), and (3) how it was implemented 
(technical features). It includes several items such as the  mHealth infrastructure, 
technology platform, user feedback and usability, and it aims to improve transparency 
in reporting, promoting a critical assessment of mHealth research evidence, and helping 
to improve the precision of future reporting of research findings (Agarwal, S., Lefevre, 
A., et al., 2016). 
 
Table 2 – mHealth evidence reporting and assessment (mERA) guidelines, including mHealth essential criteria 
(Agarwal, S., Lefevre, A., et al., 2016)  
Criteria Item No Notes 
Infrastructure (population level) 1 Availability of infrastructure to support technology operations in the 






study location (e.g. physical infrastructure such as electricity and 
connectivity) 
Technology platform interoperability 2 
Justification for the technology architecture. This includes a description 
of the software and hardware 
Health information systems (HIS) 
context 
3 Describes how the mHealth intervention can integrate into existing HIS 
Intervention delivery 4 
Description of the mHealth intervention (e.g. frequency of mobile 
communication, mode of delivery of intervention, timing and duration) 
Intervention content 5 
Description of the details of the content (as well as source and any 
modifications to the content) 
Usability/content testing 6 
Describes formative research and/or content and/or usability testing 
with target groups clearly identified 
User feedback 7 
Describes user feedback or user satisfaction with the intervention (e.g. 
usability, access, connectivity) 
Access of individual participants 8 
Mentions barriers or facilitators to the adoption of the intervention 
among study participants (e.g. economic or social barriers/facilitators) 
Cost assessment 9 
Presents basic costs assessment of the mHealth intervention from 
varying perspectives  
Adoption inputs/program entry 10 
Describe how people are informed about the program (e.g. promotional 
activities or training if relevant) 
Limitations for delivery at scale 11 Cleary presents the mHealth solution limitations for delivery at scale 
Contextual adaptability 12 
Describes the adaption (or not) of the solution to a different language, 
population or context. Any tailoring or modification of the intervention 
that resulted from pilot testing/usability is described  
Replicability 13 
Detailed intervention to support replicability (e.g. code/flowcharts of 
algorithms) 
Data security 14 Describes the data security procedures/confidentiality protocols 
Compliance with national guidelines or 
regulatory structures 
15 
Mechanisms used to assure that content or other guidance/information 
provided by the intervention is in alignment with the existing 
national/regulatory guidelines  
Fidelity of the intervention 16 
Describes the strategies employed to assess the fidelity of the 
intervention (i.e. Was the intervention delivered as planned?)  
 
4. Case Study – The Weal Life App Assessment Plan 
 
“Healthcare providers may want to stay informed due to interest in recommending 
mobile health apps as part of their treatment planning (…). However, guidance on how 
to judge the validity or worth of commercially available apps is lacking. The decision to 
recommend an app to a patient can have serious consequences if its content is 
inaccurate or if the app is ineffective or even harmful.”  







4.1 mHealth Apps: Supporting Health through Technology 
Mobile devices offer unique opportunities to design tailored solutions and reach 
populations. For healthcare professionals, a mobile device has become an integral part 
of delivering care, whilst patients have taken an active role in managing their health.  
In 2015 more than half (58,23%) of the mobile phone owners’ US population had 
downloaded a health-related app4. In 2016, more than 259,00 mobile health (mHealth) 
apps were available in the major app stores5. Yet, despite its proliferation, there remains 
lack of evidence and regulation in terms of mHealth efficacy and impact in health 
outcomes and behavioral change.  
The need for more evidence regarding the effectiveness of mHealth apps is commonly 
acknowledged, yet there are significant challenges in designing and implementing 
evaluation plans. In particular, the difficulty of trialing an app for the recommended 
period of time, and the potential for changes in technology or expectations from 
individuals. As the end-user’s usage and engagement with an app is complex, multiple 
factors (e.g. robustness of the technology, engagement strategies, interaction of the user 
with the technology, etc.) can impact the success of an intervention. To generate 
evidence and improve health promotion, a comprehensive (and dynamic) evaluation 
plan is required.    
 
4.2 The Weal Life App 
 
“We use technology to make it easier to care for one another, especially during a health 
crisis, aging or chronic illness. We value personal relationships by making the 
experience of caring for our loves ones less overwhelming, more collaborative and 
more meaningful & joyful” 
 Keely Stevenson, Founder and CEO of The Weal Life 
 
 
The Weal Life is a socially connected mHealth app designed specifically for helping 
caregivers to cope with the daily challenges of caring for a loved one. With a focus on 








four main functionalities – (1) task creation and scheduling (management tool), (2) chat, 
(3) gift registry and (4) library (“get ideas” feature in the app) - Weal recognizes trusted 
friends and family as a circle of support and makes it easier, more transparent and 
rewarding to help (See Exhibit 1 for snapshots of the app). 
The app utilizes several engagement techniques including push notifications and humor 
(“to make the experience a little lighter, a little more joyful” – Keely Stevenson, 
November 2015). The Weal Life has an extensive, searchable evidence-based 
information library (i.e. articles on a range of topics related to a specific 
disease/condition and ideas on how to help your loved one) and a wish list feature of 
needs and gifts easily connected to Amazon. Caregivers can create a new team or family 
members and friends can log in/be invited to an existing one, enabling users to create or 
assigned themselves to a specific task (e.g. Pick up Kim from chemotherapy at 5pm) 
and connect with other supporters and share messages.  
The Weal Life is the first app we are aware that focus on the patient and support circle 
informational (i.e. understanding all aspects of the situation, illness, medical/healthcare 
related resources and life resources) and psychological needs (i.e. feeling supported, 
hopeful, and a sense of control of the situation). 
Leveraging mobile technology to capture the value of relationships, The Weal Life 
intervention aims to increase the emotional, financial and logistical support family 
members and friends can give to an ill/impaired loved one and its primary caregiver; 
which Weal hypothesizes will increase the perceived social support and in particular 
reduce the caregiver’s burden level. 
 
4.3 The Weal Life Assessment Plan 
In developing the assessment plan for The Weal Life app, there was a focus on planning 
for ongoing evaluation throughout the app development cycle. This included three 
stages: (1) formative (while planning the app intervention), (2) summative (during the 
app implementation) and (3) outcome evaluation (studying the outcomes of the app 
intervention). 
The development of the app included formative evaluation with input from the end-user 







As the pilot study trial is currently proceeding, the summative and outcome evaluation 
are still being conducted. The data for these stages will be collected from participants 
via self-administered questionnaires at recruitment, baseline (month 1) and follow-up 
(month 6). The Weal Life assessment plan is detailed in Exhibit 2, and focuses 
generally on evaluating the delivery of social, emotional, financial and logistical support 
to caregivers and care recipients through a mHealth app intervention. The inclusive plan 
is based on the “Collaborative Adaptive Interactive Technology” dynamic framework 
developed by O’Grady, L., and colleagues (2009), designed to evaluate items for the 
formative, summative and outcome assessment of The Weal Life across five areas – 
people, content, technology, computer-mediated interaction and health systems 
integration. The five broad categories of criteria are described below.    
 
People  
In the case of The Weal Life, “people” refers to end-users (i.e. caregivers, care recipients 
and circle of support) and stakeholders (i.e. health insurance companies and healthcare 
professionals). The formative evaluation stage sought to identify only the end-users’ 
needs and preferences. This included a literature review, the creation of personas6, user-
testing (with think-aloud walkthrough7) and individual interviews. Stakeholders were 
not considered important to include at this stage as the company considered them not to 
have practical insights or enough awareness about the caregiving experience. The end-
user group focused on the framing of the app, and on the acceptability of the proposed 
functionalities and design. Insights about the caregivers’ perspectives, individuals’ 
intentions, needs, problems and motivations to use the app were included at all 
evaluation levels.  
Data was gathered by the conclusion of the think-aloud walkthrough studies and 
summative and outcome evaluation data will be collected via questionnaires regarding 
                                                
6	 	Personas	are	a	way	to	model,	summarize	and	communicate	about	the	end-users’	or	stakeholders’	 traits,	needs	
and	 preferences.	 Whilst	 personas	 do	 not	 represent	 a	 real	 individual,	 they	 synthetize	 significant	 information	
regarding	the	target	population	–	See	Exhibit	3	







the caregivers’ burden levels (Zarit Burden Interview8) and perceived social support 
(Social Support Index9) as part of the pilot study randomized controlled trial (RCT). For 
the RCT we’ll target caregivers with specific characteristics (please see Exhibit 6 for a 
detailed explanation of the sample selection procedures).  The outcome assessment 
includes examination of the data gathered at recruitment, baseline (month 1) and follow-
up (month 6), including The Weal Life mHealth impact on caregivers’ burden levels and 




The “content” in the case of The Weal Life refers to the constantly updated 
informational content on the “library” section (i.e. “get ideas” feature in the app) and 
the user-generated content in the chat, in the task creation management tool and in the 
wish list feature.  
In the development of the app, formative evaluation sough to test the quality and 
reliability of the library content through extensive literature reviews, caregivers’ 
perspectives, and healthcare professional insights. Understandability, functionality and 
usability will be measured in the summative phase via the MARS questionnaire 
completion. 
The Weal Life contains a socially connected chat for caregivers and supporters to 
interact with each other, a task management tool feature for users to create or assign 
themselves to a specific task and a wish list feature where users can create and purchase 
gifts. The outcome assessment will focus on collecting computerized measures in order 
                                                
8	The	Zarit	Burden	 Interview	 is	a	 self-reported	measure	developed	by	Zarit,	H.,	and	colleagues	 in	1985.	The	 total	
score	 of	 the	 Zarit	 Burden	 Interview	 reflects	 the	 overall	 level	 of	 burden	 perceived	 by	 the	 caregiver	 within	 the	
caregiving	episode	–	Exhibit	4			












to understand what role do these features play for users and what position do they have 
in the app, for instance: level of chat activity, total number of people invited to a team 
Vs. the number of people who actually joined the team, and total number of tasks 
created Vs. the total number of tasks accepted. 
 
Technology 
The software used to develop and run The Weal Life app is the “technology”. In this 
category, the formative phase included indicators such as the quality of the system 
(performance and speed), as well as how it performed with several users. Privacy of 
users and generated content was an important consideration for The Weal Life, including 
how the data is stored in order to ensure confidentiality.  
Summative assessment will involve an examination of usage statistics embedded in the 
app to answer questions such as, how people are using the app, which features are the 
most popular and how supporters are engaging with a team. In the outcome phase, we 
will look at the dynamic of The Weal Life evolution over time (e.g. how it adapts to new 
technologies, new operating system updates, new mHealth applications and social 
trends). 
 
Computer-mediated technology  
“Computer-mediated technology” refers to the evaluation of the end-users’ interactions 
with and via The Weal Life interface technology. Formative assessment included the 
think-aloud walkthroughs that measured the app usability. Additional information will 
be collected from end-users regarding their perspectives on the functionality of the app 
through the completion of the MARS questionnaire. The final outcome evaluation will 
examine content analysis and app-related metrics to explore the “community 
engagement” within the app (i.e. How The Weal Life has supported the creation of a 
“community” around the caregiver and care recipient, and how users have engaged with 
each other over time). 
 
Health Systems Integration 
The category “health systems integration” refers to the larger healthcare landscape and 






assessment included the  development  of a comprehensive framework including the 
inclusion of ethical and legal concerns. Summative evaluation wil measure the impact 
of The Weal Life in caregivers’ usage of other health services (such as external websites 
and/or  other  mHealth applications, and  visits to  healthcare  professionals in relation to 
the caregiving experience). The outcome evaluation of The Weal Life app wil include 
considerations on its sustainability and how it can be embedded into existing healthcare 
insurance plans and health services (i.e. the stakeholders). Finaly, the RCT pilot study 
includes a cost-efectiveness analysis of the intervention being analyzed.    
 
4.4 Discussion 
As mHealth technologies continue to proliferate, regulators and healthcare professionals 
wil increasingly require the ability to plan and evaluate technological interventions. 
Chalenges  persist in  developing  mHealth applications, including  privacy and security 
concerns, and the  need for  more evidence-base regarding their eficacy,  usability and 
cost-efectiveness. Wil the developed framework be able to continuously monitor and 
evaluate mobile based health applications? Or wil this toolset, once again, be outdated 
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of	the	end-user	(Zarit, H., and colleagues, 1985)		
	









1. that	 because	 of	 the	 time	 you	 spend	 with	 your	 relative	 that	 you	 don’t	 have	
enough	time	for	yourself?		





Exhibit	 5	 –	 Social	 Support	 Index	 used	 for	 the	 outcome	 evaluation	 of	 the	 end-user	
(McCubbin, I., Patterson, J., & Glynn, T., 1982)		
	















9. There	 are	 times	 when	 family	 members	 do	 things	 that	 make	 other	 family	
members	unhappy	




















US	 primary	 caregiver	 population12.	 Inclusion	 criteria	 comprises:	 (1)	 being	 primary	
caretaker	of	an	 ill	 relative/friend/neighbor,	 (2)	younger	than	60	years	old,	 (3)	English	
speaker,	(4)	smartphone	owner,	(5)	living	in	San	Francisco	Area.	In	order	to	have	valid	
results,	it	will	be	important	to	include	in	the	analysis	the	app	usability	by	the	end-users	
(i.e.	 monitor	 app	 analytics,	 such	 as	 number	 of	 logins	 per	 week).	 Through	 the	
completion	of	 the	MARS	questionnaire	 throughout	 the	 evaluation	plan	we’ll	 also	 be	
able	to	understand	if	a	caregiver	doesn’t	find	the	app	useful	or	resourceful.			












































































Over	a	3-month	period,	The	Weal	 Life	will	approach	 family	 caregivers	within	 its	own	
network	of	contacts.	For	those	who	decide	to	enroll,	an	informative	email	will	be	sent.	
Through	a	link	embed	in	the	email,	individuals	will	have	access	to	a	descriptive	survey	
–	 in	 order	 to	 collect	 participants’	 demographic	 information.	 Participants	 who	 don’t	
complete	the	initial	survey	will	be	excluded.	
	
Exhibit	 7–	Mobile	App	Rating	 Scale	 (MARS)	questionnaire	used	 in	 several	 evaluation	




1. Entertainment:	 Is	 the	 app	 fun/entertaining	 to	 use?	Does	 it	 use	 any	 strategies	 to	
increase	engagement	through	entertainment?	(e.g.	through	gamification)?	
2. Interest:	 Is	 the	 app	 interesting	 to	 use?	 Does	 it	 use	 any	 strategies	 to	 increase	
engagement	by	presenting	its	components	in	an	interesting	way?	
3. Customization:	 Does	 it	 provide/retain	 all	 necessary	 setting/preferences	 for	 app	
features	(e.g.	sound,	content,	notifications,	etc.)?	






5. Teaching Notes   
 
5.1 Learning Objectives 
The Weal Life App Assessment Plan case study, aims to help students understand how 






app interventions, whilst raising awareness for the importance of providing clear-based 
evidence about mHealth products. Additionally, students attending technological, 
innovation or entrepreneurial seminars can become familiar with a successfully 
developed mHealth app and understand the relevant factors to be considered when 
building a health-tech solution. 
The proposed learning objectives of this case are:  
1. To understand the importance of properly evaluate a mHealth app intervention; 
2. To highlight the importance of properly developed indicators, metrics and outcome 
evaluation;  
3. To understand the relevant components and phases to be considered while 
developing a health-tech solution; 
4. To become aware of an existing dynamic framework for mHealth solutions 
evaluation; 
5. To be able to apply the same comprehensive evaluation plan to a project developed 
by themselves or proposed by a Professor; 
6. To become familiar with an existing mHealth solution for caregivers; 
 
5 2 Teaching Questions 
In order to support a brainstorming and practical session on mHealth app evaluation 
plans, the following three teaching questions (TQs) are recommended. 
 
TQ1: Why do mHealth app developers need to incorporate comprehensive evaluation 
plans into their products? 
 
TQ2: Which are the key factors that mHealth app developers have to consider in order 
to properly assess their technology? 
 
TQ3 (if applicable): Use the previous framework and insights to develop your own app 
assessment plan.  
 
Through their own reading, students should individually reflect on The Weal Life 






comprehensive evaluation plans into mHealth technology, whilst understanding its basic 
structure and framework.    
The professor can actively create groups of 4-5 students, and guide the practical and 
brainstorming session with the help of the teaching questions and learning objectives. If 
applicable (for instance, in a Lean Entrepreneurship Project Class) students can use the 
presented evaluation framework to create an assessment plan to evaluate their own 
projects.     
 
5 3 Discussion 
The following answers will provide some insights in how to properly explore The Weal 
Life Assessment Plan case study. The proposed teaching questions are exclusively based 
on the case study and The Weal Life example.   
 
TQ1: Why do mHealth app developers need to incorporate comprehensive evaluation 
plans into their products? 
 
This answer can be found on the first (4.1) and final (4.4) chapters. mHealth app 
developers need to incorporate comprehensive evaluation plans into their products 
because: 
• mHealth apps are evolving technologies inserted in a dynamic and rapidly 
changing environment (technological and consumers’ expectations constantly 
change and adapt to new trends and needs). Locking down an intervention 
during a static trial decreases the likelihood that useful information will come 
from the experiment (Mohr, D., et al., 2015); 
• As evolving (rather than static) technologies, mHealth apps need to be evaluated 
through dynamic and comprehensive plans - able to adjust and constantly 
improve. Integrating ongoing quality improvement into assessment plans can 
spur innovation, allowing for the mHealth technology to develop over time 
(Mohr, D., et al., 2015); 
• As a proliferating technology, healthcare providers and regulators will 
increasingly require the ability to properly evaluate mHealth technologies 






recommendations. “We need to determine whether something is effective before 
it can be of value” (O’Grady, L., and colleagues, 2009); 
• As a complex construct, the success of a mHealth intervention is dependent on 
multiple factors (such as: robustness of the technology, engagement strategies, 
interaction of the user with the technology, and design); 
• There is little evidence-base regarding the efficacy, usability, cost effectiveness 
and general health outcomes of mHealth app interventions;  
Additionally, students should brainstorm other ideas that have not been considered, but 
that could be relevant. For instance: 
• Reliance on mHealth interventions, which are not subject to regulatory 
oversight, can delay the diagnosis and even harm patients. In 2013, researchers 
from the University of Pittsburg Medical Center (Wolf, J., Moreau, J., et al., 
2013) found three out of four skin cancer diagnosis apps to miss at least 1 in 3 
melanomas. mHealth interventions carry the risk of causing more harm than 
good (O’Grady, L., and colleagues, 2009); 
• Evidence about the efficacy of mHealth applications is an emerging field and 
appropriate evaluation skills are needed (White, B., Burns, S., et al., 2016); 
• mHealth technologies are rapidly becoming an integral part of the modern 
society (O’Grady, L., and colleagues, 2009); 
• Health interventions efficacy and effectiveness are usually tested in RCTs. 
However, RCTs have a long time lag from the initiation to the outcome 
publication. In mHealth interventions the time lag is crucial, as these 
technologies may become obsolete before the experiment is completed. In many 
cases, the evolving nature of mHealth apps means that some components need to 
be continuously improved during a trial (Kumar, S., et al., 2014);    
 
TQ2: Which are the key factors that mHealth app developers have to consider in order 
to properly assess their technology? 
 
This answer can be found on the third chapter (4.3). The key factors, mHealth 






• Ongoing evaluation throughout the app development cycle. As mobile usage 
becomes increasingly sophisticated and personalized, broad assessment plans 
are crucial in determining the efficacy of mHealth technologies (White, B., 
Burns, S., et al., 2016). To generate evidence, assessment needs to be conducted 
throughout the implementation of a mHealth app, not only at the conclusion 
(Lobo, R., Burns, SK., & Petrich, M., 2014); 
• Emphasis on three different stages: (1) formative (while planning the app 
intervention), (2) summative (during the app implementation) and (3) outcome 
evaluation (studying the outcomes of the app intervention) (O’Grady, L., and 
colleagues, 2009); 
• An individual’s usage and engagement with a mobile app is so complex that 
several factors can impact the results of the intervention. To determine its 
success, assessment plans should consider both usage feedback and outcome 
measures (White, B., Burns, S., et al., 2016; O’Grady, L., and colleagues, 2009) 
Thus, definition of relevant outcomes, measurement techniques and criteria of 
assessment are crucial; 
• The complex web of components that can impact the result of a mobile 
intervention (such as: robustness of the technology, engagement strategies, 
interaction of the user with the technology, and design) (O’Grady, L., and 
colleagues, 2009).  
 
TQ3 (if applicable): Use the previous framework and insights to develop your own app 
assessment plan.  
 
In this case, students will be able to apply the presented framework to develop and 
evaluate their own project. It may be important to give them access to the original paper 
“Collaborative Adaptive Interactive Technology” written by O’Grady, L., and 
colleagues (2009).  
The framework that proposes formative, summative and outcome evaluation for 
adaptive and interactive applications is described in detail below. In order to implement 
it, students must follow the instructions descripted in the evaluation tasks. In some 






the components listed below. In these situations, we suggest students to focus on the 
areas of interest – people, content, technology, computer-mediated interaction, and 
health systems integration – that are the most relevant to the objectives of the 
project/course.    
 
Table 3 – Evaluation schema: collaborative, adaptive and interactive technology (O’Grady, L., and colleagues, 2009)  
 
Formative 
Development and laboratory 
testing 
Summative 








tasks: formal needs 
assessment. 
Identification of key 
characteristics of 
potential users, e.g. 
through individual 
interviews or the 
creation of personas) 







and broader interests) 
• End users’ traits 
(Evaluation tasks: 









• End users’ 
perspectives 
(Evaluation tasks: 
collect feedback from 
end users regarding 
their 
intentions/motivations 
to use the app and 
their satisfaction with 
the intervention) * 
 
*MARS Questionnaire 
• Patient outcomes 
(Evaluation tasks: 
investigate the 
impact of the 











assessment of any 
changes/lack of 
changes within the 
patient-
provider/caregiver-
patient relationship ) 
Content 
• Quality and credibility 
(Evaluation tasks: 









• Quality and credibility 
(Evaluation tasks: 
assess users’ 
perceptions of these 
attributes, e.g. 
surveys. Do the users 
find the content 
trustworthy and 
believable?)  * 




tasks: assessment of 
user-generated 
content on its form –
narrative, numerical 
- and nature – 
advice, opinion, 
personal information 
or personal support, 








must be evaluated with 
standardized metrics 
and by experts or 




perceptions of these 
attributes, e.g. 
surveys. Overall 
assessment of the 
usefulness of the 
information on the 
app) * 




perceptions of these 
attributes, e.g. 
surveys. Is the 
information applicable 
and usable to the end 
user as an 




• Positioning of user-
generated content 
(Evaluation tasks: 
evaluate how the 
content provided by 
users is framed 
within the site. E.g. is 
there any mechanism 
for 
feedback/dialogue 
















• System reliability and 
speed (Evaluation 
tasks: collection of 
usage statistics and 
app analytics) 
• Positioning within 
current technology 
• Standards compliance 
• Dynamic evolution 
(Evaluation tasks: 
assess how well the 
app responds to 
technological or 
societal trends, e.g. 
software updates and 






for the app 
improvement 



















• Collaboration * 
• Findability * 
• Community 
development * 
• Evolution of 
collaboration * 
 









and usability testing 
with sample 
populations of target 
users, e.g. think-aloud 
walkthroughs) 
 
* (Evaluation tasks: 
users’ feedback, e.g. 
consultations with 
users, online surveys, 
measures of user 
activity…) 
and longitudinal 
analysis of evidence 
of collaboration 






• Definition of 
evaluation metrics and 
process (Evaluation 
tasks: whether/how 
well evaluation was 














assessment of how the 
app affects services 
utilization – usage 
rate for healthcare 
system/community 
services - care 
coordination – ways in 
which the app might 
be affecting delivery of 
health services - and 
patient safety – 
assessment of 
how/whether the app 
is affecting patient 
safety indicators such 
as the appropriate use 
of medications, e.g. 
questionnaires) 
• Public impact 
(Evaluation tasks: 
assess general effects 







gains from the use of 
the app, e.g. 
economic analysis) 
• Intended effect 
(Evaluation tasks: 
suitability of the app 
as a mean to achieve 



















6 Conclusions, Limitations and Future Research 
6 1 Conclusions 
The case study highlights the need for health-tech companies to evaluate and properly 
measure their products, alongside with the acknowledged necessity to produce 
evidence-base understanding on the topic. Whilst there has been a significant increase 
on the number of trialed mHealth technologies, the majority makes use of static 
procedures, not suitable for complex and dynamic constructs such as mHealth app 
technologies. Henceforth, in order to leverage health through technology, a better 
understanding on how to properly evaluate efficacy, usability, behavior and health 
outcomes is needed. 
The Weal Life desire in producing real impact, thus facilitating the caregiving 
experience, aligns with the need to properly evaluate these technologies.  
The main research question was trying to understand why and how should health-tech 
companies evaluate their mHealth app technologies, as well as the key factors and 
methodologies these companies have to adopt in order to undertake impact 
measurement.  
Regarding our first research question – Synthetize why health-tech companies should 
evaluate their mHealth app technologies - the study revealed that the quick proliferation 
and dissemination of mHealth apps across the patient spectrum outpaces the ability to 
properly evaluate their efficacy, security, accuracy and cost-effectiveness. Indeed, 
health-specific collaborative, adaptive, and interactive technologies are emerging, 
promising to transform roles, rights and responsibilities of all stakeholders within the 
system (Deshpande, A. & Jadad, A, 2006). Being the case, as any other set of 
interventions, mHealth technologies also carry the risk of causing more harm than good. 
Although these technologies may seem appealing, the lack of evidence in improving 
health outcomes and/or change health behavior is a barrier to the trustful and 
widespread adoption in the healthcare sector. Ultimately, there is no sufficient evidence-
base knowledge for healthcare providers and promoters to safely incorporate mHealth 
apps into their plans, prescriptions or recommendations. We should assume the 
responsibility to “look beyond the hype, and to dissect what works and what doesn’t” 






Evaluation plays a critical role in high quality design, efficient development, and 
effective implementation of mHealth interventions. The development of appropriate 
frameworks will help to ensure mobile-based health technologies live up to expectations 
and contribute to the improvement of health. As the need for more evidence regarding 
the effectiveness of mHealth apps is currently acknowledged, there are significant 
challenges in designing and implementing evaluation plans. Regarding our second 
research question – Evaluate the importance and need to adopt a comprehensive 
approach to mHealth apps and to undertake impact measurement - mobile-based health 
interventions characteristics justify the need for a comprehensive approach to undertake 
impact measurement. As evolving (i.e. subject to constant updates and user experience 
improvements) and complex (i.e. dependent on multiple factors, such as people, content 
information, technology used, etc.…) technologies inserted in a dynamic and rapidly 
changing environment (i.e. mHealth technologies can quickly become obsolete if they 
don’t properly adapt to the market/customers’ needs or constant technological 
advances), mobile-based health interventions need a complete, adaptable assessment 
plan covering all the development stages and the multiple factors the success of the app 
is dependent on. This methodology assures ongoing monitoring and improvement 
throughout the app development cycle, preventing the app to be launched with obsolete 
or irrelevant characteristics, whilst generating evidence-base regarding its efficacy, 
usability and cost-effectiveness. Additionally,          
Ultimately we approached our third research question – Examine how mHealth apps 
should be measured - by developing a holistic, multi-staged evaluation framework 
(based on the framework proposed by O’Grady, L., and colleagues, 2009) to properly 
measure and evaluate mHealth app interventions. With an emphasis on ongoing and 
adaptable assessment, the methodology organizes (1) formative (i.e. while planning the 
app intervention), (2) summative (i.e. during the app implementation), and (3) outcome 
evaluation (i.e. studying the outcomes of the app implementation) into five major areas 
of interest, (1) people, (2) content, (3) technology, (4) computer-mediated interaction, 
and (5) health systems integration. Applying this useful tool should help researchers to 
generate comparable results and superior evidence-based knowledge. As a consequence, 






build legitimacy, but mostly, helps to oversee processes of value creation to health-tech 
companies. 
 
6 1 Limitations and Future Research 
As the study only starts to identify some important characteristics and procedures, 
expanded research methods have to be deployed in order to develop more powerful and 
standardized tools. Therefore, some limitations of the research should be considered. 
Firstly, The Weal Life is still evaluating their app performance. As a result, the 
assessment plan proposed here has not been fully tested. It is hoped that as the evidence 
base for mHealth interventions develops, the applicability of the assessment plan will be 
tested. Secondly, future research is required to determine the suitability and reliability 
of the plan across multiple mHealth and other app domains. Additional work might 
have to be undertaken to ensure the generalizability of the framework proposed. Future 
improvements of the evaluation plan terminology and items are likely to be required, as 
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